Husmann Douglas A, Viers Boyd R
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Transl Androl Urol. 2020 Feb;9(1):132-141. doi: 10.21037/tau.2019.09.06.
Management of the severely impaired patient (pt) with a neurogenic bladder (NGB) and complete urethral destruction employs three therapeutic options; bladder neck closure (BNC) with ileovesicostomy, BNC with suprapubic tube (SPT) placement or in pts with an end-stage bladder, cystectomy with enteric conduit diversion. This paper was performed to test the hypothesis that pts managed with an ileovesicostomy would have the best long-term prognosis.
Patients with a NGB and complete urethral destruction managed between 1986-2018 were reviewed. Three treatment populations were assessed, pts treated with BNC with ileovesicostomy, BNC with SPT placement or cystectomy with enteric conduit diversion. A minimal follow-up interval of 2 years was necessary to be entered into the study. The number of uroseptic episodes, development of urolithiasis, the onset of new renal scars, ≥ stage 3 chronic renal failure, or need for additional surgery were recorded. Statistical evaluations used either chi-squared contingency table analysis, Fisher's exact 2-tailed tests, or Kaplan-Meier curve analysis where indicated. P values of <0.05 were considered significant.
Ten pts were managed by cystectomy, and enteric conduit, 17 by BNC and ileovesicostomy and 21 by BNC and SPT placement, median follow up of 8 yrs (range, 2-30 yrs). No significant differences between the three groups regarding the development of urolithiasis (30%, 3/10 pts; 53%, 9/17 pts; 52%, 11/21 pts; respectively), new onset of renal scarring (30%, 6/20 kidneys; 41%, 14/34 kidneys; 45%, 19/42 kidneys; respectively) or stage 3 chronic renal failure (40%, 4/10 pts; 47%, 8/17 pts; 24%, 5/21 pts; respectively. However, the number of hospitalizations for uroseptic episodes significantly increased in patients managed with an ileal conduit (60%, 6/10 pts) and ileovesicostomy (82%; 14/17 pts) compared to those maintained with a SPT (29%, 6/21 pts) P=0.025 and 0.006, respectively. When evaluating the need for delayed surgical intervention due to either urolithiasis or other complications, a total of 50% (5/10 pts) of the patients managed by an ileal conduit, 88% (15/17 pts) of the ileovesicostomy and 52% (11/21 pts) of the patients with a SPT required additional operations. In essence, significantly more pts undergoing BNC and ileovesicostomy required delayed surgical interventions for complications arising from the surgery compared to patients managed with either a cystectomy and ileal conduit (P=0.0285) or BNC and SPT placement (P=0.0180).
In severely impaired pts with a NGB and urinary outlet destruction, BNC and ileovesicostomy are associated with a significantly increased incidence of urosepsis and late surgical complications that required operative intervention compared to alternative treatments. This finding has resulted in the abandonment of the ileovesicostomy from our surgical armamentarium.
对于患有神经源性膀胱(NGB)且尿道完全损毁的重症患者,有三种治疗选择;膀胱颈闭合术(BNC)联合回肠膀胱造口术、BNC联合耻骨上造瘘管(SPT)置入术,或者对于终末期膀胱患者,行膀胱切除术并进行肠代膀胱术。本文旨在验证以下假设:采用回肠膀胱造口术治疗的患者具有最佳的长期预后。
回顾了1986年至2018年间接受治疗的患有NGB且尿道完全损毁的患者。评估了三个治疗组,即接受BNC联合回肠膀胱造口术、BNC联合SPT置入术或膀胱切除术并进行肠代膀胱术的患者。纳入研究的患者需至少有2年的随访期。记录尿脓毒症发作次数、尿路结石的发生情况、新出现的肾瘢痕、≥3期慢性肾衰竭或是否需要再次手术。统计评估采用卡方列联表分析、Fisher精确双侧检验,或在适当情况下采用Kaplan-Meier曲线分析。P值<0.05被认为具有统计学意义。
10例患者接受了膀胱切除术并进行肠代膀胱术,17例接受了BNC联合回肠膀胱造口术,21例接受了BNC联合SPT置入术,中位随访时间为8年(范围为2至30年)。三组在尿路结石的发生情况(分别为30%,3/10例;53%,9/17例;52%,11/21例)、新出现的肾瘢痕(分别为30%,6/20个肾脏;41%,14/34个肾脏;45%,19/42个肾脏)或3期慢性肾衰竭(分别为40%,4/10例;47%,8/17例;24%,5/21例)方面无显著差异。然而,与采用SPT的患者相比,采用回肠膀胱术(60%,6/10例)和回肠膀胱造口术(82%;14/17例)的患者因尿脓毒症发作而住院的次数显著增加(分别为29%,6/21例),P值分别为0.025和0.006。在评估因尿路结石或其他并发症而需要延迟手术干预的情况时,采用回肠膀胱术的患者中有50%(5/10例)、采用回肠膀胱造口术的患者中有88%(15/17例)以及采用SPT的患者中有52%(11/21例)需要再次手术。实际上,与接受膀胱切除术并进行回肠膀胱术(P=0.0285)或BNC联合SPT置入术(P=0.0180)的患者相比,接受BNC联合回肠膀胱造口术的患者因手术并发症而需要延迟手术干预的情况显著更多。
在患有NGB且尿路出口损毁的重症患者中,与其他治疗方法相比,BNC联合回肠膀胱造口术导致尿脓毒症和需要手术干预的晚期手术并发症的发生率显著增加。这一发现导致我们在手术治疗方案中放弃了回肠膀胱造口术。